BRIEF-Eton Pharmaceuticals Acquires Galzin

Reuters
03 Jan
BRIEF-Eton Pharmaceuticals Acquires Galzin

Jan 3 (Reuters) - Eton Pharmaceuticals Inc ETON.O:

  • ETON PHARMACEUTICALS ADVANCES ITS COMMITMENT TO RARE DISEASE WITH THE ACQUISITION OF GALZIN®

  • ETON PHARMACEUTICALS INC - TO COMMERCIALIZE GALZIN IN U.S. IN Q1 2025

  • ETON PHARMACEUTICALS INC: HAS ALSO ACQUIRED EUROPEAN RIGHTS TO GALZIN

Source text: ID:nGNX1LkkCW

Further company coverage: ETON.O

((Reuters.Briefs@thomsonreuters.com;))

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10